Bob

Bob (Boxiang) is an experienced biostatistician currently employed at Parexel since March 2020, where responsibilities include managing clinical trials in oncology, immunology, and metabolism. Prior to this role, Bob worked as a research analyst at Harvard University, focusing on deep learning techniques to enhance T-cell receptor engineering for cancer treatment. Additional experience includes an analyst position in healthcare mergers and acquisitions at the Industrial and Commercial Bank of China, a biostatistics internship at Otsuka Pharmaceutical, and a consultancy role at Starr Insurance Companies. Bob holds a Master of Science in Biostatistics from Yale University and a Bachelor of Arts in Mathematics and Economics from Brandeis University.